Twin Tree Management’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.74M Buy
+5,911
New +$1.56M 0.04% 560
2025
Q4
– Sell
-1,485
Closed -$232K – 1462
2025
Q3
$232K Buy
+1,485
New +$236K ﹤0.01% 1334
2024
Q3
– Sell
-545
Closed -$113K – 1556
2024
Q2
$113K Buy
+545
New +$123K ﹤0.01% 1175
2022
Q3
– Sell
-7,060
Closed -$1.52M – 1401
2022
Q2
$1.51M Sell
7,060
-19,130
-73% -$4.67M ﹤0.01% 1164
2022
Q1
$7.44M Buy
+26,190
New +$8.08M 0.01% 790
2021
Q4
– Sell
-9,033
Closed -$3.51M – 1616
2021
Q3
$3.73M Buy
+9,033
New +$3.75M 0.01% 875
2021
Q2
– Sell
-521
Closed -$151K – 1384
2021
Q1
$151K Buy
521
+503
+2,794% +$140K ﹤0.01% 1157
2020
Q4
$4K Sell
18
-428
-96% -$102K ﹤0.01% 1231
2020
Q3
$101K Sell
446
-14,039
-97% -$2.91M ﹤0.01% 1068
2020
Q2
$2.52M Sell
14,485
-1,530
-10% -$244K 0.01% 825
2020
Q1
$2.02M Buy
16,015
+14,041
+711% +$2.11M 0.01% 713
2019
Q4
$302K Sell
1,974
-3,227
-62% -$447K ﹤0.01% 991
2019
Q3
$688K Sell
5,201
-10,059
-66% -$1.35M ﹤0.01% 877
2019
Q2
$2.16M Sell
15,260
-7,512
-33% -$1.02M 0.01% 642
2019
Q1
$3.31M Buy
22,772
+14,260
+168% +$1.87M 0.02% 547
2018
Q4
$963K Buy
+8,512
New +$1.07M 0.01% 861
2018
Q3
– Sell
-4,526
Closed -$508K – 1085
2018
Q2
$508K Buy
+4,526
New +$489K ﹤0.01% 895

Other funds holding CRL

Twin Tree Management's CRL Position: Q3 2026 in Review

Twin Tree Management opened a new position in Charles River Laboratories (CRL) in Q3 2026: 5,911 shares worth $1.74M. The stake represents 0.04% of the portfolio and ranks #560 among its holdings. This is a return to the name: Twin Tree Management previously reported a position in CRL as recently as Q3 2025.

Twin Tree Management first reported a position in CRL in Q2 2018 and has held it in 17 quarters since. The position peaked at $7.44M in Q1 2022. 646 funds tracked by Wall St. Rank hold CRL as of Q3 2026.

  • Twin Tree Management held 5,911 shares of Charles River Laboratories worth $1.74M as of Q3 2026.
  • Charles River Laboratories was a new Twin Tree Management position in Q3 2026.
  • Charles River Laboratories made up 0.04% of Twin Tree Management's portfolio in Q3 2026, its #560 holding.
  • Twin Tree Management first reported a position in Charles River Laboratories in Q2 2018 and has held it in 17 quarters since.
  • Twin Tree Management's Charles River Laboratories position peaked at $7.44M in Q1 2022.
  • 646 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2026.

Based on Twin Tree Management's 13F filing for Q3 2026, filed 10 Nov 2026.